Abstract
Gene transfer to pancreatic islets may prove useful in preventing islet cell destruction and prolonging islet graft survival after transplantation in patients with type 1 diabetes mellitus (T1DM). Potentially, a host of therapeutically relevant transgenes may be incorporated into an appropriate gene delivery vehicle and used for islet modification. An increasing understanding of the molecular pathogenesis of immune-mediated beta cell death has served to highlight molecules which have become suitable candidates for promoting islet cell survival in the face of oxidative stress. This review aims to give an overview of some conventional gene transfer strategies aimed at promoting islet cell survival in the face of cytokine onslaught. These strategies target three aspects of islet cell physiology: redox status and antioxidant defence, anti-apoptotic gene expression and mediators of cytokine signal transduction pathways.
| Original language | English (Ireland) |
|---|---|
| Pages (from-to) | 241-252 |
| Number of pages | 12 |
| Journal | Diabetes |
| Volume | 22 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 May 2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anti-apoptotic
- Antioxidants
- Beta cells
- Cytokines
- Cytoprotection
- Gene transfer
- Islet allografts
- Oxidative stress
- Vectors
Fingerprint
Dive into the research topics of 'Cytoprotection of beta cells: Rational gene transfer strategies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver